ImmunoPrecise Antibodies's Earnings Outlook
Portfolio Pulse from Benzinga Insights
ImmunoPrecise Antibodies (NASDAQ:IPA) is set to release its latest quarterly earnings report on July 7, 2023. Analysts estimate an EPS of $-0.13. The company's past performance shows a trend of beating EPS estimates but experiencing a drop in share price. The stock is currently trading at $3.03, down 27.72% over the last 52-week period.
July 06, 2023 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
ImmunoPrecise Antibodies is expected to report an EPS of $-0.13. Despite beating EPS estimates in the past, the company's share price has typically dropped. The stock is down 27.72% over the last year.
The company has a history of beating EPS estimates but this has not translated into a rise in share price. Given the negative trend in the stock's performance over the past year, it is likely that the upcoming earnings report could further pressure the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100